Skip to main content
Top

Current Cardiology Reports

Issue 5/2020

Content (11 Articles)

Cardiovascular Complications in Patients with COVID-19: Consequences of Viral Toxicities and Host Immune Response

Han Zhu, June-Wha Rhee, Paul Cheng, Sarah Waliany, Amy Chang, Ronald M. Witteles, Holden Maecker, Mark M. Davis, Patricia K. Nguyen, Sean M. Wu

Correction to: Cardiovascular Complications in Patients with COVID-19: Consequences of Viral Toxicities and Host Immune Response

Han Zhu, June-Wha Rhee, Paul Cheng, Sarah Waliany, Amy Chang, Ronald M. Witteles, Holden Maecker, Mark M. Davis, Patricia K. Nguyen, Sean M. Wu

Cardiovascular Risks in Patients with COVID-19: Potential Mechanisms and Areas of Uncertainty

Paul Cheng, Han Zhu, Ronald M. Witteles, Joseph C Wu, Thomas Quertermous, Sean M. Wu, June-Wha Rhee

Sepsis-Induced Cardiomyopathy: a Comprehensive Review

Michael L’Heureux, Michael Sternberg, Lisa Brath, Jeremy Turlington, Markos G. Kashiouris

Autoimmunity in Acute Myocarditis: How Immunopathogenesis Steers New Directions for Diagnosis and Treatment

  • Open Access
  • Myocarditis
  • Myocardial Disease (AA and G Sinagra, Section Editors)

Karina Bruestle, Klaus Hackner, Gudrun Kreye, Bettina Heidecker

High-Sensitivity Troponins in Cardiovascular Disease

Michael C. Kontos, Jeremy S. Turlington

Four Dimensions of the Cardiac Myocyte Epigenome: from Fetal to Adult Heart

  • Open Access
  • Epigenetics
  • Regenerative Medicine (SM Wu, Section Editor)

Carolin Rommel, Lutz Hein

Cellular Reprogramming Approaches to Engineer Cardiac Pacemakers

Angel Xiao, Hee Cheol Cho

Mechanisms of Neonatal Heart Regeneration

  • Regenerative Medicine (SM Wu, Section Editor)

Alisson C. Cardoso, Ana Helena M. Pereira, Hesham A. Sadek

Use of a Discharge Educational Strategy Versus Standard Discharge Care on Reduction of Vascular Risk in Patients with Stroke and Transient Ischemic Attack

Anantha R. Vellipuram, Zain Hussain, Prashanth Rawla, Gustavo Rodriguez, Alberto Maud, Salvador Cruz-Flores, Rakesh Khatri

Next-generation MRI contrast agents: preparing the field (Link opens in a new window)

New MRI contrast agents are reshaping diagnostic imaging, promising lower gadolinium exposure amid evolving practice guidelines. How can you optimise contrast selection, dosing, and patient care in this rapidly advancing field?

This content is intended for healthcare professionals outside of the UK.

Independent Medical Education Grant:
  • Bayer HealthCare Pharmaceuticals Inc.
Learn more Link opens in a new window
Image Credits
Abstract graphic of layered, concentric circular shapes in bright green, pink, blue, and purple on a dark blue background. The rings and segments form a complex radial pattern without text/© Springer Health+ IME